 The investigators design two cohort studies, and plan to enroll 32 healthy volunteers in cohort 1 and 16 patients with coronary artery disease undergoing percutaneous coronary intervention PCI and receiving dual anti-platelet therapy ticagrelor 90mg bid aspirin 100mg daily for 7 days 